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with 5 MBq/mouse and three untreated controls which were 
injected with α-HIBA only. No impairment of animal kidney 
function was observed to date. 
Tumor visualization was readily achieved with both 152Tb-
labeled peptides and, due to the high sensitivity of this 
scanner, it was possible to also image the tumors at late time 
points after injection of the mice. 
Conclusion: The latest run of experiments in the PSI/ISOLDE 
collaboration proved to be the most successful to date, with 
reproducible harvesting of 149Tb and 152Tb and its subsequent 
chemical separation from impurities.  The product was 
successfully labelled to peptides and folate and injected into 
mice for imaging and long-term studies to determine kidney 
damage, in the case of 149Tb.  Following these encouraging 
results, more ambitious studies are planned in future. 
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Over the past years, dual energy CT (DECT) scanners have 
been installed in many radiology departments. Recently, also 
possibilities are under investigation to use this equipment for 
radiotherapy purposes. Several strategies using DECT imaging 
may allow optimization of radiation treatment in a variety of 
fields: e.g. tumour detection and characterization, improved 
dose calculation accuracy, objective normal tissue function 
quantification. DECT allows a robust way of material 
characterization that easily can quantify the electron density 
and effective atomic number. These approaches improve 
radiotherapy dose calculation accuracy. Especially in 
brachytherapy and proton therapy this is necessary due to 
the larger uncertainties in dose calculation compared to high 
energy photon treatments. Other possible applications 
involve advanced metal artifact reduction techniques. The 
use of iodinated contrast material allows an objective 
quantification for quantitative assessment of perfusion of 
tumours and normal tissues. Future perspectives for DECT for 
radiotherapy will be discussed together with the next steps 
for implementation in clinical practice. 
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Objective: A validated CT-based radiomic signature showed 
to have prognostic information for lung cancer patients1,2. 
The prognostic value of radiomic image features derived from 
cone-beam CT (CBCT) images has not yet been described. 
Furthermore, due to the fact that a CBCT image is acquired 
prior to each fraction it has the potential to monitor 
response to treatment. The goal of this study was to 
investigate the stability and correlation between features of 
the radiomic signature derived from planning CT vs. kV-CBCT 
and between CBCTs of different fractions. 
Material/Methods: A total of 26 stage II-III NSCLC patients 
who received radiation therapy were included in this study. 
The planning CT (CT1), the CBCT prior to the first (CBCT-FX1) 
and second fraction (CBCT-FX2) were used in this study (see 
Figure). CBCT images were registered to CT1 using an 
automatic rigid registration prior to feature extraction. The 
prognostic radiomic signature1 consists of four features: I) 
tumor intensity: ‘Energy’, II) texture: ‘Grey Level 
Nonuniformity, III) wavelet: ‘Grey Level Nonuniformity HLH’ 
and IV) shape: ‘Compactness’. Since a rigid registration was 
used without redelineation, the fourth feature ‘Compactness’ 
was not analyzed since no changes were performed to the 
shape. For the remaining three features, the correlation 
between feature values derived from (1) CT1 and CBCT-FX1 
and (2) CBCT-FX1 and CBCT-FX2 were analyzed. Correlations 
were calculated using an intraclass correlation coefficient 
ICC(2,1).  
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Figure: Images of A) planning CT and B) kV-cone-beam CT  
 
Results: All three features of the radiomic signature I) 
‘Energy’, II) ‘Grey Level Nonuniformity and III) ‘Grey Level 
Nonuniformity HLH’ showed correlation of ICC>0.8 between 
CT1 and CBCT-FX1 (ICC = 0.98, 0.88 and 0.81 respectively) 
and between CBCT-FX1 and CBCT-FX2 (ICC = 0.89, 0.83 and 
0.95 respectively).  
Conclusion: Three features that previously showed to have 
prognostic performance in lung and head & neck cancer 
patients for CT images show a correlation above 0.8 between 
CT1 and CBCT-FX1. The features also show an ICC>0.8 for 
CBCT-FX1 vs. CBCT-FX2, which suggests stability of those 
features using CBCT imaging. These results show the 
potential of CBCT imaging in monitoring treatment and 
acquiring prognostic and predictive information. In the 
future, radiomic features derived from CBCT images will be 
investigated to monitor changes of CBCT features over the 
course of treatment (the so-called “Delta-radiomics” 
approach) and to evaluate its prognostic significance.  
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SiPMs allow a dramatic improvement of PET performance. 
The good timing performance of SiPMs will result in better 
Time Of Flight time resolution, and therefore in better 
effective sensitivity.  The small and independent 
photodetector pixels allow using one-to-one coupling 
between a SiPM pixels and a LYSO crystals. This will result in 
significant improvement of the spatial resolution compared 
to PMT base systems. To take advantage of SiPMs in PET 
applications, it is mandatory to have highly integrated 
electronics readout.  
The present work expands the research in SiPM-based PET-
ToF pursued by the authors since several years, in particular 
developing the TOFPET readout ASIC, a 64 channel mixed-
S108  ICTR-PHE 2016 
 
mode chip designed in 130 nm CMOS technology [1]. We 
present results of a PET-ToF demonstrator scanner based on 
this ASIC and featuring a highly integrated readout and DAQ 
system. 
The Detector Module is composed of 8 matrices of 4x4 LYSO 
scintillating crystals, each with a size of 3.1 x 3.1 x 15 mm3. 
These matrices are optically coupled to 8 arrays of 
Hamamatsu TSV-MPPCs. The crystal matrices and associated 
MPPCs plug directly in the Frontend Boards forming a 
compact detecting unit with active area 59x29 mm2. The 
present results were obtained with a partially assembled ring 
(16 Modules) corresponding to 2048 SiPM readout channels. 
The Frontend board integrates two ASICs allowing the 
readout and digitization of 128 MPPC pixels. On-chip TDCs 
produce two time measurements allowing the determination 
of the event time and of the time-over-threshold. A 
Concentrator board reads the data from eight Frontend 
boards (1024 channels) and transmits assembled data frames 
through a serial link to the PCIe based DAQ board in the data 
acquisition PC.  
At present the PET-ToF demonstrator is fully assembled and 
in operation (Figure 1). We will report on the detector 
performance, including energy resolution, spatial resolution, 
time resolution and rate performance of the system. Images 
with phantoms will also be presented. 
 
 
Figure 1 - Flood histogram of the full scanner obtained 
with a Na22 point source. 
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The cell membrane not only functions as a physical barrier 
between the intracellular and extracellular space, it harbors 
critical components involved in receptor-ligand interactions, 
signal transduction and drug uptake. Targeting the cell 
membrane represents a novel strategy to improve anti-
cancer therapy. Our work focuses on two different 
approaches. The first involves lipid rafts. These are dynamic, 
cholesterol/sphingolipid-enriched microdomains within 
biological membranes, and play a crucial role in the 
induction of (apoptotic) cell death by radiation, pro-
apoptotic receptor agonists and synthetic alkyl-
phospholipids. 
The second approach addresses insufficient drug delivery into 
tumor cells, which represents a major limitation of cytostatic 
therapy. We found that co-formulation and co-administration 
of liposome-encapsulated chemotherapy and synthetic short-
chain sphingolipids (SCS) improves drug availability by 
enhancing intracellular drug uptake. Specific biophysical 
requirements of both the SCS (chain length and polarity) and 
chemotherapeutic agent (amphiphilicity) determine the 
optimal conditions for improved drug delivery. Doxorubicine 
and mitoxantrone are two frequently prescribed 
chemotherapeutic agents that benefit from this cell 
membrane-targeting approach. In vitro and in vivo studies 
demonstrate higher drug efficacy and/or lower toxicity in 
relevant tumor model systems. Mechanistic analyses 
demonstrate that SCS preferentially insert into tumor cell 
membranes enhancing the intrinsic capacity to translocate 
amphiphilic drugs.  
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Purpose: Modern radiotherapy is based on using small 
radiation fields and their segments. For clinical use they 
need to be verified by measurement. But measurement of 
small radiosurgery fields is very problematic task because of 
dosimetry challenges, such as loss of charged particle 
equilibrium, accurate positioning of detector and its small 
size. Purpose of this study is to assess new synthetic single 
crystal MicroDiamond PTW 60019 detector. Its dosimetry 
characteristics from the manufacturer and especially small 
size of its sensitive volume (0.004 mm3) make the detector 
promising tool for this task. 
Materials and Method: In this study basic dosimetry 
characteristics of MicroDiamond detector were verified in 
clinical linear accelerator photon and electron beams. 
Measurements involved short time stability and detector 
response dependence on dose rate, beam energy, 
temperature and angular dependence. In addition, 
measurement of relative output factors for Leksell Gamma 
Knife Perfexion was performed in order to test dosimeter 
performance for small fields. Collimator sizes 4 mm, 8 mm 
and 16 mm were used. Results obtained by this detector 
were compared with ELEKTA reference values and 
independent Monte Carlo Geant4 simulation. 
Results: Stabilization of detector response was always 
performed before starting measurement. For this purpose 40 
minutes irradiation in reference conditions was necessary 
(corresponding delivered dose was about 100 Gy). After this 
time the response was relatively stable with difference 
between maximum and minimum value 0.25% and standard 
deviation of all measurements 0.07% within an hour 
(normalized for this and all subsequent measurements to 
mean value of response). Dose rate dependence was 
measured for 6 different dose rates. Difference between 
maximum and minimum value was 0.24%. Energy dependence 
of detector was performed for 2 photon energies (6 and 18 
MV) and 5 electron energies (6-20 MeV). Difference between 
maximum and minimum photon beam values was 0.12%, for 
electron beams this difference was 4.54% with standard 
deviation of response values 1.62%. Results for temperature 
and angular dependence are not finalized yet. Finally, results 
of comparative measurement for relative output factors of 
the Leksell Gamma Knife for 4 and 8 mm collimators were 
0.831 and 0.900, respectively. These values are in a good 
agreement with vendor values (0.814 and 0.900) and Monte 
Carlo simulation. 
Conclusion: New MicroDiamond PTW 60019 detector appears 
to be a promising detector for relative output factor 
measurements in small radiosurgery fields. Verified 
dosimetric properties of the detector are in limits set by 
manufacturer. However, relatively long pre-irradiation 
process is necessary prior to measurement before the 
detector can produce reliable data. Further measurements 
will follow. This work was supported by CTU grant no. 
SGS15/217/OHK4/3T/14. 
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